Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

484 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical characterisation and outcomes of human clade IIb mpox virus disease - a European multicentre observational cohort study (MOSAIC).
Pesonel E, Laouénan C, Guiraud L, Bourner J, Hoffmann I, Molino D, Tardivon C, Bachelet D, Mentré F, Amstutz A, Merson L, Rojek A, Cervantes Gonzalez M, Antinori A, Castagna A, Nozza S, Pourcher V, Libois A, Dunning J, Tacconelli E, Hites M, De La Calle Prieto F, Horby P, Yazdanpanah Y, Calmy A, Lescure FX, Olliaro P; MOSAIC Study Group. Pesonel E, et al. Among authors: olliaro p. Clin Infect Dis. 2025 Jan 3:ciae657. doi: 10.1093/cid/ciae657. Online ahead of print. Clin Infect Dis. 2025. PMID: 39749987
The priority review voucher: a misconceived quid pro quo.
Olliaro P, Torreele E. Olliaro P, et al. BMJ Glob Health. 2024 Dec 3;9(12):e015933. doi: 10.1136/bmjgh-2024-015933. BMJ Glob Health. 2024. PMID: 39631790 Free PMC article. No abstract available.
Therapeutics for Nipah virus disease: a systematic review to support prioritisation of drug candidates for clinical trials.
Chan XHS, Haeusler IL, Choy BJK, Hassan MZ, Takata J, Hurst TP, Jones LM, Loganathan S, Harriss E, Dunning J, Tarning J, Carroll MW, Horby PW, Olliaro PL. Chan XHS, et al. Among authors: olliaro pl. Lancet Microbe. 2024 Nov 12:101002. doi: 10.1016/j.lanmic.2024.101002. Online ahead of print. Lancet Microbe. 2024. PMID: 39549708 Free article. Review.
Long Covid: a global health issue - a prospective, cohort study set in four continents.
Pazukhina E, Garcia-Gallo E, Reyes LF, Kildal AB, Jassat W, Dryden M, Holter JC, Chatterjee A, Gomez K, Søraas A, Puntoni M, Latronico N, Bozza FA, Edelstein M, Gonçalves BP, Kartsonaki C, Kruglova O, Gaião S, Chow YP, Doshi Y, Duque Vallejo SI, Ibáñez-Prada ED, Fuentes YV, Hastie C, O'Hara ME, Balan V, Menkir T, Merson L, Kelly S, Citarella BW, Semple MG, Scott JT, Munblit D, Sigfrid L; ISARIC Clinical Characterisation Group and ISARIC Global Covid-19 follow up working group. Pazukhina E, et al. BMJ Glob Health. 2024 Oct 21;9(10):e015245. doi: 10.1136/bmjgh-2024-015245. BMJ Glob Health. 2024. PMID: 39433402 Free PMC article.
Impact of a package of point-of-care diagnostic tests, a clinical diagnostic algorithm and adherence training on antibiotic prescriptions for the management of non-severe acute febrile illness in primary health facilities during the COVID-19 pandemic in Burkina Faso.
Kiemde F, Nkeramahame J, Ibarz AB, Dittrich S, Olliaro P, Valia D, Rouamba T, Kabore B, Kone AN, Sawadogo S, Bere AW, Some DY, Some AM, Compaore A, Horgan P, Weber S, Keller T, Tinto H. Kiemde F, et al. Among authors: olliaro p. BMC Infect Dis. 2024 Aug 27;24(1):870. doi: 10.1186/s12879-024-09787-y. BMC Infect Dis. 2024. PMID: 39192209 Free PMC article. Clinical Trial.
At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods.
Mesinovic M, Wong XC, Rajahram GS, Citarella BW, Peariasamy KM, van Someren Greve F, Olliaro P, Merson L, Clifton L, Kartsonaki C; ISARIC Characterisation Group. Mesinovic M, et al. Among authors: olliaro p. Sci Rep. 2024 Jul 16;14(1):16387. doi: 10.1038/s41598-024-63212-7. Sci Rep. 2024. PMID: 39013928 Free PMC article.
An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus an aminoglycoside + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial-an update to the published protocol.
Randremanana RV, Raberahona M, de Dieu Randria MJ, Bourner J, Zadonirina G, Razananaivo H, Mayouya-Gamana T, Mangahasimbola R, Pesonel E, Gillesen A, Rajerison M, Andrianaivoarimanana V, Edwards T, Horby P, Olliaro P. Randremanana RV, et al. Among authors: olliaro p. Trials. 2024 Jul 5;25(1):457. doi: 10.1186/s13063-024-08302-7. Trials. 2024. PMID: 38970065 Free PMC article.
Cost-Effectiveness of Test-and-Treat Strategies to Reduce the Antibiotic Prescription Rate for Acute Febrile Illness in Primary Healthcare Clinics in Africa.
van Dorst PWM, van der Pol S, Olliaro P, Dittrich S, Nkeramahame J, Postma MJ, Boersma C, van Asselt ADI. van Dorst PWM, et al. Among authors: olliaro p. Appl Health Econ Health Policy. 2024 Sep;22(5):701-715. doi: 10.1007/s40258-024-00889-x. Epub 2024 May 25. Appl Health Econ Health Policy. 2024. PMID: 38796659 Free PMC article.
Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms.
Citarella BW, Kartsonaki C, Ibáñez-Prada ED, Gonçalves BP, Baruch J, Escher M, Pritchard MG, Wei J, Philippy F, Dagens A, Hall M, Lee J, Kutsogiannis DJ, Wils EJ, Fernandes MA, Tirupakuzhi Vijayaraghavan BK, Panda PK, Martin-Loeches I, Ohshimo S, Fatoni AZ, Horby P, Dunning J, Rello J, Merson L, Rojek A, Vaillant M, Olliaro P, Reyes LF; ISARIC Clinical Characterisation Group. Citarella BW, et al. Among authors: olliaro p. Heliyon. 2024 May 4;10(10):e29591. doi: 10.1016/j.heliyon.2024.e29591. eCollection 2024 May 30. Heliyon. 2024. PMID: 38779000 Free PMC article.
484 results